Skip to main content

Table 2 Odds of ADT use in multilevel models as a function of urologist characteristics, stratified by era

From: Reimbursement cuts and changes in urologist use of androgen deprivation therapy for prostate cancer

Urologist characteristics

ADT use by era

 

a2000-2002

a2004-2007

 
 

Odds ratio

95% CI

Odds ratio

95% CI

p-value interaction with era

Years in practice (per 5 years)

1.01

(0.97, 1.05)

1.03

(1.00 ,1.07)

0.47

Board certification

     

Yes

ref

 

ref

  

No

1.01

(0.82, 1.24)

1.06

(0.89, 1.28)

0.94

Academic affiliation

     

Major or minor

ref

 

ref

  

None

1.32

(1.17, 1.56)

1.34

(1.15, 1.56)

0.68

Patient panel size

     

<14

ref

 

ref

 

0.13

14 - 44

1.02

(0.84, 1.25)

0.93

(0.77, 1.12)

 

45 - 74

1.23

(0.99, 1.54)

1.03

(0.84, 1.26)

 

≥75

1.10

(0.86, 1.40)

0.89

(0.71, 1.11)

 
  1. aBased on multilevel model with patient age, comorbidity, ethnicity, SEER region, tumor stage, grade, year of diagnosis, census tract education, and census tract poverty entered as “level 1” variables and urologist characteristics entered as “level 2” variables. Urologist sex was not entered into the models due to low female sample size. Urologist age was not entered into the models due to collinearity with the years in practice variable.
Back to article page

BMC Urology

ISSN: 1471-2490

Contact us